(A-B) Both a TMEM165 KO cell line (TM-KO-3) and a mutant cell line (TM-Mut-1, insertion of Cys-Tyr residues between Leu279 and Cys280) showed increased resistance to Stx1 (A) and Stx2 (B). (C) TM-KO-3 and TM-Mut-1 cells showed reduced sensitivities to ricin (10 ng/mL) compared with WT cells. (D-E) TM-KO-3 and TM-Mut-1 cells showed similar sensitivities to A-Dtx (D) (Student’s t test, p > 0.05), but reduced sensitivity to Ctx (E) compared with WT cells. (F) TM-KO-3 and TM-Mut-1 cells showed reduced binding of Stx1 and CtxB. Ectopic expression of TMEM165 (with an N-terminal triple HA tag) restored binding of Stx1 and CtxB in both cell lines. Scale bar, 5 μm. Representative images are from one of three independent experiments. (G) Mass spectro...
<p>(A) Sphingomyelin and glycosphingolipid synthesis pathway. (B) CHO-APP cells were treated with th...
<p>(<b>A</b>) Immunofluorescence staining for Stx16 expression in src-shRNA-MDCK and sh<i>Stx16</i>-...
Myxoid Liposarcomas (MLS), characterized by the expression of FUS-CHOP fusion gene are clinically ve...
(A-B) TM9SF2 KO cells (SF2-KO-8 and SF2-KO-9) showed increased resistance to Stx1 (A) and Stx2 (B). ...
(A-B) Two single clones of LAPTM4A KO 5637 cells (LA-KO-10 and LA-KO-12) are resistant to Stx1 and S...
(A) A range of human cell lines were exposed to a series of concentrations of Stx1 for 72 h and cell...
<p>(A) PRX3 expression in cells treated with scrambled control (Sc) or PRX3 siRNA for 48 and 72 hr. ...
Glycosylation is a fundamental modification of proteins and membrane lipids. Toxins that utilize gly...
Glycosylation is a fundamental modification of proteins and membrane lipids. Toxins that utilize gly...
(A) HA-tagged TMEM165 colocalizes with Giantin and TGN46 in 5637 cells. (B) Pretreatment of TM-Mut-1...
Summary: Glycosphingolipids (GSLs) are produced by various GSL-synthesizing enzymes, but post-transl...
<p>(A) Comparative mDC capture of distinct LUV<sub>HIV-tRed</sub> containing Cer, GM1a, or GM1 lacki...
<p>A) E-cadherin mRNA levels in 6DT1 shCtrl, 6DT1-shTpx2#1, and 6DT1-shTpx2#2 cells were measured by...
Shiga toxin (Stx, synonymous to verotoxin, VT) binds with high and low affinity to the globo-series ...
Antibody reactivity toward GM3 and GM2 gangliosides of 10 human glioma and 1 melanoma cell lines was...
<p>(A) Sphingomyelin and glycosphingolipid synthesis pathway. (B) CHO-APP cells were treated with th...
<p>(<b>A</b>) Immunofluorescence staining for Stx16 expression in src-shRNA-MDCK and sh<i>Stx16</i>-...
Myxoid Liposarcomas (MLS), characterized by the expression of FUS-CHOP fusion gene are clinically ve...
(A-B) TM9SF2 KO cells (SF2-KO-8 and SF2-KO-9) showed increased resistance to Stx1 (A) and Stx2 (B). ...
(A-B) Two single clones of LAPTM4A KO 5637 cells (LA-KO-10 and LA-KO-12) are resistant to Stx1 and S...
(A) A range of human cell lines were exposed to a series of concentrations of Stx1 for 72 h and cell...
<p>(A) PRX3 expression in cells treated with scrambled control (Sc) or PRX3 siRNA for 48 and 72 hr. ...
Glycosylation is a fundamental modification of proteins and membrane lipids. Toxins that utilize gly...
Glycosylation is a fundamental modification of proteins and membrane lipids. Toxins that utilize gly...
(A) HA-tagged TMEM165 colocalizes with Giantin and TGN46 in 5637 cells. (B) Pretreatment of TM-Mut-1...
Summary: Glycosphingolipids (GSLs) are produced by various GSL-synthesizing enzymes, but post-transl...
<p>(A) Comparative mDC capture of distinct LUV<sub>HIV-tRed</sub> containing Cer, GM1a, or GM1 lacki...
<p>A) E-cadherin mRNA levels in 6DT1 shCtrl, 6DT1-shTpx2#1, and 6DT1-shTpx2#2 cells were measured by...
Shiga toxin (Stx, synonymous to verotoxin, VT) binds with high and low affinity to the globo-series ...
Antibody reactivity toward GM3 and GM2 gangliosides of 10 human glioma and 1 melanoma cell lines was...
<p>(A) Sphingomyelin and glycosphingolipid synthesis pathway. (B) CHO-APP cells were treated with th...
<p>(<b>A</b>) Immunofluorescence staining for Stx16 expression in src-shRNA-MDCK and sh<i>Stx16</i>-...
Myxoid Liposarcomas (MLS), characterized by the expression of FUS-CHOP fusion gene are clinically ve...